TLSIWTriSalus Life Sciences, Inc.同业对比
TriSalus Life Sciences, Inc. 与SIC 3841 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TLSIW本股 | $55M#8 | — | 8.5x#11 | 1.2x#6 | 53.4%#2 | -30.6%#11 | -59.7%#9 | -598.9%#10 | — | 5#4 | -61.7%#3 | — |
| GUTS | $95M#1 | — | — | — | -100.0%#13 | -105.2%#13 | — | — | — | — | — | — |
| LNSR | $88M#2 | 35.8x#4 | 5.9x#10 | 1.7x#7 | 12.4%#6 | -9.2%#9 | -47.6%#7 | -230.0%#8 | — | — | — | — |
| SKIN | $87M#3 | — | 1.6x#6 | 0.3x#1 | -10.0%#9 | 67.4%#3 | -6.9%#3 | -17.1%#3 | — | — | — | — |
| LUNG | $85M#4 | — | 2.2x#8 | 0.9x#5 | 8.0%#7 | 4.2%#6 | -59.3%#8 | -137.8%#6 | -257.0%#5 | 3#5 | 28.4%#1 | — |
| DRIO | $65M#5 | 1.2x#2 | 1.2x#3 | 2.9x#11 | -17.3%#10 | 2.4%#7 | -163.9%#10 | -75.7%#5 | -41.6%#3 | 3#5 | — | — |
| SKYA | $57M#6 | — | 0.4x#1 | 280.1x#13 | — | -2938.9%#15 | -132145.5%#13 | -179.6%#7 | -181.9%#4 | — | — | — |
| TELA | $56M#7 | — | — | 0.7x#4 | 15.8%#4 | -2.6%#8 | -42.0%#5 | — | -257.2%#6 | 3#5 | — | — |
| MDAI | $51M#9 | — | — | 2.6x#10 | -33.6%#11 | 50.1%#4 | -43.8%#6 | — | — | 3#5 | — | — |
| SRTS | $50M#10 | — | 1.4x#5 | 1.8x#8 | -34.3%#12 | -216.1%#14 | -37.5%#4 | -20.9%#4 | — | — | — | — |
| NEPH | $48M#11 | 27.6x#3 | 5.7x#9 | 2.6x#9 | 32.7%#3 | 1513.5%#1 | 6.1%#1 | 14.3%#1 | 26.8%#1 | 7#1 | -2.5%#2 | — |
| AMIX | $4M#14 | — | 1.3x#4 | — | — | -46.5%#12 | — | -528.6%#9 | -743.5%#9 | — | — | — |
| XAIR | $3M#15 | 0.2x#1 | 1.6x#7 | 0.4x#3 | 107.3%#1 | 28.7%#5 | -378.2%#11 | -1664.9%#12 | -347.6%#7 | 7#1 | — | — |
| XTNT | $45M#12 | — | 1.1x#2 | 0.3x#2 | 14.2%#5 | 130.2%#2 | 5.4%#2 | 0.0%#2 | 5.0%#2 | 7#1 | — | — |
| PETV | $39M#13 | — | 28.5x#12 | 33.9x#12 | 0.8%#8 | -24.7%#10 | -793.9%#12 | -772.3%#11 | -647.5%#8 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-17。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议